Lenalidomide Impurity 66 CAS CATO-C4X-190366
| CAS No. | CATO-C4X-190366 |
| Molecular Formula | C15H14Br4N2O |
| Molecular Weight | 557.90 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
As a process- or degradation-related impurity, Lenalidomide Impurity 66 (CAS CATO-C4X-190366, C15H14Br4N2O) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Based on its molecular formula C15H14Br4N2O, Lenalidomide Impurity 66 contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, bromine substitution; these features give the compound characteristic absorption bands in UV spectroscopy. The molecular weight of 557.90 g/mol is directly relevant to the identification of the molecular ion in mass spectrometry. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Lenalidomide Impurity 66 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C15H14Br4N2O |
| Molecular Weight | 557.90 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at room temperature, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 8.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Br-containing |
| Nitrogen Atoms | 2 |
Related Lenalidomide Standards
- Lenalidomide-PEG5-C2-acid (CAS 2376139-68-1)
- Lenalidomide Lactosamine Adduct (Mixture of Diastereomers) (CAS CATO-C4X-190373)
- Lenalidomide Impurity 40 (CAS CATO-C4X-190340)
- Lenalidomide Impurity 42 (CAS CATO-C4X-190342)
- Lenalidomide Impurity 41 (CAS CATO-C4X-190341)
- Lenalidomide Impurity 46 (CAS CATO-C4X-190346)
- Lenalidomide-PEG4-C2-acid (CAS 2225148-45-6)
- Lenalidomide-PEG4-C2-azide (CAS 2399455-55-9)
Recommended Standards
- N1-[4-(trifluoromethyl)phenyl]-2-({5-(6-chloro-3-pyridyl)-4-[3-(trifluoromethyl)phenyl]-4H-1,2,4-triazol-3-yl}thio)acetamide (CAS 680217-07-6)
- 2,2'-(2,5-Dibromo-1,4-phenylene)bis(3-bromothiophene) (CAS 1217503-06-4)
- {[(4aR,6R,7R,7aR)-6-{6-Amino-8-[(4-chlorophenyl)sulfanyl]-9H-purin-9-yl}-7-methoxy-2-oxo-hexahydro-2λ-furo[3,2-d][1,3,2]dioxaphosphinin-2-yl]oxy}methyl acetate (CAS 1152197-23-3)
- 9-cis-Retinyl Stearate-d5 (CAS 1331643-11-8)
- Levofloxacin EP Impurity C(Levofloxacin N-Oxide) (CAS 117678-38-3)
- Aprepitant Impurity 27 (CAS 183901-47-5)
- Oxacillin Impurity 19 (CAS CATO-C4X-232119)
- 3-Butyl-1-(2-fluorophenyl)-4,5-dihydro-1H-pyrazol-5-one (CAS 1354939-32-4)
- N-(Pyridin-4-ylmethyl)pyridin-2-amine (CAS 16552-51-5)
- N-Cyclopropyl-6-nitrobenzo[d][1,3]dioxol-5-amine (CAS 1692154-08-7)
- Methyl Z-L-Alaninamide (CAS 33628-84-1)
- 2-(3-((2,3-Dichlorophenoxy)methyl)phenyl)benzo[d]thiazole (CAS 339096-04-7)
- 2,2'-(2-Hydroxypropane-1,3-diyldisulfonyl)bis(ethan-1-ol) (CAS 67006-34-2)
- Semaglutide impurity 275 (CAS CATO-C4X-2226275)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com